AIG
HZNP

American International Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

American International Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,661
Closed -$424K – 3070
2023
Q3 		$424K Sell
3,661
-253
-6% -$27.2K ﹤0.01% 1699
2023
Q2 		$403K Buy
3,914
+695
+22% +$73.3K ﹤0.01% 1783
2023
Q1 		$351K Sell
3,219
-93
-3% -$10.3K ﹤0.01% 1798
2022
Q4 		$377K Sell
3,312
-125
-4% -$10.4K ﹤0.01% 1759
2022
Q3 		$213K Buy
3,437
+12
+0.4% +$838 ﹤0.01% 2122
2022
Q2 		$273K Buy
3,425
+793
+30% +$75.1K ﹤0.01% 1975
2022
Q1 		$277K Sell
2,632
-50
-2% -$4.87K ﹤0.01% 2054
2021
Q4 		$289K Sell
2,682
-97
-3% -$10.6K ﹤0.01% 2148
2021
Q3 		$304K Sell
2,779
-302
-10% -$31.4K ﹤0.01% 2169
2021
Q2 		$289 Sell
3,081
-1,143
-27% -$105K ﹤0.01% 2277
2021
Q1 		$389 Sell
4,224
-499
-11% -$42.1K ﹤0.01% 1970
2020
Q4 		$345 Sell
4,723
-190
-4% -$14.1K ﹤0.01% 1970
2020
Q3 		$382K Buy
4,913
+82
+2% +$5.64K ﹤0.01% 1737
2020
Q2 		$269K Buy
4,831
+1,666
+53% +$71.3K ﹤0.01% 1959
2020
Q1 		$94K Buy
3,165
+123
+4% +$4.16K ﹤0.01% 2343
2019
Q4 		$110K Sell
3,042
-106
-3% -$3.25K ﹤0.01% 2570
2019
Q3 		$86K Hold
3,148
– – ﹤0.01% 2699
2019
Q2 		$76K Sell
3,148
-111,777
-97% -$2.84M ﹤0.01% 2818
2019
Q1 		$3.04M Buy
114,925
+4,352
+4% +$103K 0.01% 886
2018
Q4 		$2.16M Buy
110,573
+868
+0.8% +$17K 0.01% 950
2018
Q3 		$2.15M Buy
109,705
+1,978
+2% +$37.6K 0.01% 1016
2018
Q2 		$1.78M Buy
107,727
+3,344
+3% +$51K 0.01% 1064
2018
Q1 		$1.48M Sell
104,383
-5,614
-5% -$82.9K 0.01% 1077
2017
Q4 		$1.61M Buy
109,997
+520
+0.5% +$7.3K 0.01% 1111
2017
Q3 		$1.39M Buy
109,477
+8,185
+8% +$104K ﹤0.01% 1157
2017
Q2 		$1.2M Buy
101,292
+3,617
+4% +$45K ﹤0.01% 1175
2017
Q1 		$1.44M Buy
97,675
+4,888
+5% +$79.2K 0.01% 1035
2016
Q4 		$1.5M Sell
92,787
-239
-0.3% -$4.33K 0.01% 1035
2016
Q3 		$1.69M Buy
93,026
+142
+0.2% +$2.77K 0.01% 969
2016
Q2 		$1.53M Buy
92,884
+88,829
+2,191% +$1.44M 0.01% 987
2016
Q1 		$67K Sell
4,055
-2,144
-35% -$37.5K ﹤0.01% 3709
2015
Q4 		$134K Sell
6,199
-19,841
-76% -$386K ﹤0.01% 3232
2015
Q3 		$516K Buy
26,040
+18,526
+247% +$585K ﹤0.01% 1993
2015
Q2 		$261K Sell
7,514
-39,742
-84% -$1.21M ﹤0.01% 2759
2015
Q1 		$1.23M Buy
47,256
+5,136
+12% +$94.1K 0.01% 1465
2014
Q4 		$543K Sell
42,120
-1,618
-4% -$20.3K ﹤0.01% 2072
2014
Q3 		$537K Sell
43,738
-31
-0.1% -$360 ﹤0.01% 2082
2014
Q2 		$692K Buy
43,769
+7,733
+21% +$110K ﹤0.01% 1890
2014
Q1 		$545K Buy
36,036
+1,841
+5% +$20.8K ﹤0.01% 2006
2013
Q4 		$261K Sell
34,195
-344
-1% -$1.85K ﹤0.01% 2552
2013
Q3 		$117K Buy
34,539
+7,987
+30% +$21.1K ﹤0.01% 3201
2013
Q2 		$65.3K Buy
+26,552
New +$63.7K ﹤0.01% 3437

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

American International Group's HZNP Position: Q4 2023 in Review

American International Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 3,661 shares — an estimated $424K sold.

American International Group first reported a position in HZNP in Q2 2013 and held it in 42 quarters. The position peaked at $3.04M in Q1 2019. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • American International Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • American International Group sold 3,661 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $424K.
  • American International Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 42 quarters.
  • American International Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.04M in Q1 2019.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on American International Group's 13F filing for Q4 2023, filed 13 Feb 2024.